ketoconazole has been researched along with piragliatin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boldrin, M; Georgy, A; Liang, Z; Zhai, S; Zhi, J | 1 |
1 trial(s) available for ketoconazole and piragliatin
| Article | Year |
|---|---|
Exploratory effects of a strong CYP3A inhibitor (ketoconazole), a strong CYP3A inducer (rifampicin), and concomitant ethanol on piragliatin pharmacokinetics and pharmacodynamics in type 2 diabetic patients.
Topics: Adult; Aged; Benzeneacetamides; Blood Glucose; Cross-Over Studies; Cytochrome P-450 CYP3A Inducers; Cytochrome P-450 CYP3A Inhibitors; Diabetes Mellitus, Type 2; Double-Blind Method; Ethanol; Female; Humans; Hypoglycemic Agents; Ketoconazole; Male; Middle Aged; Rifampin | 2016 |